Camp4 Therapeutics (CAMP) Enterprise Value (2023 - 2026)
Camp4 Therapeutics recorded quarterly Enterprise Value of -$99.9 million in Q1 2026, up 9.85% quarter-over-quarter from -$110.9 million in Q4 2025, and down 102.72% year-over-year from $3.7 billion in Q1 2025.
Camp4 Therapeutics' Enterprise Value history runs 4 years deep, the most recent figure standing at -$99.9 million for Q1 2026.
- In Q1 2026, Enterprise Value fell 102.72% year-over-year to -$99.9 million; the TTM figure through Mar 2026 stood at -$99.9 million (down 102.72% YoY), while the FY2025 annual figure was -$110.9 million, down 73.12% from the prior year.
- Enterprise Value came in at -$99.9 million for Q1 2026 at Camp4 Therapeutics, up from -$110.9 million in the prior quarter.
- In the past five years, Enterprise Value ranged from a high of -$2.5 million in Q3 2024 to a low of -$110.9 million in Q4 2025.
- A 4-year average of -$58.9 million and a median of -$50.5 million in 2023 frame the typical range for Enterprise Value.
- Across the five-year window, Enterprise Value jumped 94.99% in 2024 and sank 2878.64% in 2025, its largest moves.
- Camp4 Therapeutics' Enterprise Value stood at -$38.4 million in 2023, then sank by 66.86% to -$64.0 million in 2024, then sank by 73.12% to -$110.9 million in 2025, then advanced by 9.85% to -$99.9 million in 2026.
- According to Business Quant data, Enterprise Value over the past three periods registered -$99.9 million, -$110.9 million, and -$75.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -2.32 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | -32.30 Mn |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -286.70 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | -61.46 Mn |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -2.77 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | -7.25 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | -18.44 Mn |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -8.75 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | -3.01 Bn |
| 10 | Camp4 Therapeutics | 245.89 Mn | 245.89 Mn | - | -99.94 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -99.94 Mn |
| Dec 31, 2025 | -110.86 Mn |
| Sep 30, 2025 | -75.30 Mn |
| Jun 30, 2025 | -39.05 Mn |
| Mar 31, 2025 | -49.30 Mn |
| Dec 31, 2024 | -64.04 Mn |
| Sep 30, 2024 | -2.53 Mn |
| Dec 31, 2023 | -38.38 Mn |
| Sep 30, 2023 | -50.47 Mn |